Quantamental Technologies’s XBiotech XBIT Stock Holding History

Quantamental Technologies’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3	Closed	–	–	1855
2019 Q1	$0	Hold	3	–	–	﹤0.01%	1820
2018 Q4	$0	Buy	+3	New	+$12	﹤0.01%	1321

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Quantamental Technologies's XBIT Position: Q2 2019 in Review

Quantamental Technologies sold out of XBiotech (XBIT) in Q2 2019, closing a stake of 3 shares.

Quantamental Technologies first reported a position in XBIT in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 43 funds tracked by Wall St. Rank hold XBIT as of Q2 2019.

Quantamental Technologies reported no remaining XBiotech position as of Q2 2019 after selling out during the quarter.
Quantamental Technologies sold 3 XBiotech shares in Q2 2019.
Quantamental Technologies first reported a position in XBiotech in Q4 2018 and held it in 2 quarters.
Quantamental Technologies's XBiotech position peaked at $0 in Q1 2019.
43 funds tracked by Wall St. Rank held XBiotech as of Q2 2019.

Based on Quantamental Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.